Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies - Drug Trials For Money - Paid Clinical Trials

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
Conditions:   Advanced Bladder Carcinoma;   Advanced Lung Non-Small Cell Carcinoma;   Advanced Malignant Solid Neoplasm;   Advanced Melanoma;   Advanced Merkel Cell Carcinoma;   Advanced Renal Cell Carcinoma;   Clinical Stage III Cutaneous Melanoma AJCC v8;   Clinical Stage III Merkel Cell Carcinoma AJCC v8;   Clinical Stage IV Cutaneous Melanoma AJCC v8;   Clinical Stage IV Merkel Cell Carcinoma AJCC v8;   Pathologic Stage III Cutaneous Melanoma AJCC v8;   Pathologic Stage III Merkel Cell Carcinoma AJCC v8;   Pathologic Stage IIIA Cutaneous Melanoma AJCC v8;   Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8;   Pathologic Stage IIIB Cutaneous Melanoma AJCC v8;   Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8;   Pathologic Stage IIIC Cutaneous Melanoma AJCC v8;   Pathologic Stage IIID Cutaneous Melanoma AJCC v8;   Pathologic Stage IV Cutaneous Melanoma AJCC v8;   Pathologic Stage IV Merkel Cell Carcinoma AJCC v8;   Stage III Bladder Cancer AJCC v8;   Stage III Lung Cancer AJCC v8;   Stage III Renal Cell Cancer AJCC v8;   Stage IIIA Bladder Cancer AJCC v8;   Stage IIIA Lung Cancer AJCC v8;   Stage IIIB Bladder Cancer AJCC v8;   Stage IIIB Lung Cancer AJCC v8;   Stage IIIC Lung Cancer AJCC v8;   Stage IV Bladder Cancer AJCC v8;   Stage IV Lung Cancer AJCC v8;   Stage IV Renal Cell Cancer AJCC v8;   Stage IVA Bladder Cancer AJCC v8;   Stage IVA Lung Cancer AJCC v8;   Stage IVB Bladder Cancer AJCC v8;   Stage IVB Lung Cancer AJCC v8
Interventions:   Biological: Atezolizumab;   Drug: Avelumab;   Biological: Durvalumab;   Biological: Nivolumab;   Biological: Pembrolizumab;   Drug: Plinabulin;   Radiation: Radiation Therapy
Sponsor:   M.D. Anderson Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 27, 2021 / by / in
Comments